Rns Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth %
- Profit Growth 58.94%
- Ebitda 58.33%
- Total Assets %
About Rns Pharmaceuticals
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MH2006PTC163984
- Company No.
163984
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2006
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rns Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasant Chavan  | Director | 23-Aug-2006 | Current |
| Ankit Parekh | Director | 23-Aug-2006 | Current |
| Binoy Parekh | Director | 23-Aug-2006 | Current |
| Mohan Chavan | Director | 23-Aug-2006 | Current |
| Mukesh Chitalia | Director | 23-Aug-2006 | Current |
Financial Performance of Rns Pharmaceuticals.
Rns Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 58.94% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rns Pharmaceuticals?
In 2021, Rns Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellness Forever Medicare LimitedMohan Chavan is a mutual person
Ipc Healthcare Private LimitedMohan Chavan and Vasant Chavan are mutual person
Amore Health Essentials Private LimitedMohan Chavan is a mutual person
Rahul Distributors Private LimitedMohan Chavan and Vasant Chavan are mutual person
- Rahul Welfare Foundation
Mohan Chavan and Vasant Chavan are mutual person
Indravati Hospital & Research Centre LlpVasant Chavan is a mutual person
Charges (Loans)
₹0
₹20.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2014 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
| 27 Sep 2014 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
How Many Employees Work at Rns Pharmaceuticals?
Unlock and access historical data on people associated with Rns Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rns Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rns Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.